Human Vaccine Market - Global Outlook and Forecast 2021-2027
Report Code: KNJ776939 No. of Pages: 103 Category: Pharmaceuticals and Healthcare
Publisher: Date of Publish:
Publisher: Date of Publish:
This report contains market size and forecasts of Human Vaccine in global, including the following market information:
Global Human Vaccine Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global Human Vaccine Market Sales, 2016-2021, 2022-2027, (M Doses)
Global top five Human Vaccine companies in 2020 (%)
The global Human Vaccine market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Human Vaccine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Human Vaccine Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (M Doses)
Global Human Vaccine Market Segment Percentages, By Type, 2020 (%)
Varicella
Influenza
Polio
Hepatitis A
Rabies
BCG
Hepatitis B
Pertussis, Diphtheria, Tetanus
Pneumococcal
Rota vaccine
Global Human Vaccine Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (M Doses)
Global Human Vaccine Market Segment Percentages, By Application, 2020 (%)
Adults
Children
Global Human Vaccine Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions) & (M Doses)
Global Human Vaccine Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Human Vaccine revenues in global market, 2016-2021 (Estimated), ($ millions)
Key companies Human Vaccine revenues share in global market, 2020 (%)
Key companies Human Vaccine sales in global market, 2016-2021 (Estimated), (M Doses)
Key companies Human Vaccine sales share in global market, 2020 (%)
Further, the report presents profiles of competitors in the market, key players include:
CNBG
Changsheng Life
Zhifei
ChengDa Bio
Kangtai
SINOVAC BIOTECH
Hissen
Walvax Biotechnology
GSK
SANOFI
Rong An
NuoCheng Bio
Hualan Bio
Tiantan biological
Changchun Baike
Adimmune
Zhongyianke Biotech
1 Introduction to Research & Analysis Reports
1.1 Human Vaccine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Human Vaccine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Human Vaccine Overall Market Size
2.1 Global Human Vaccine Market Size: 2021 VS 2027
2.2 Global Human Vaccine Revenue, Prospects & Forecasts: 2016-2027
2.3 Global Human Vaccine Sales (Consumption): 2016-2027
3 Company Landscape
3.1 Top Human Vaccine Players in Global Market
3.2 Top Global Human Vaccine Companies Ranked by Revenue
3.3 Global Human Vaccine Revenue by Companies
3.4 Global Human Vaccine Sales by Companies
3.5 Global Human Vaccine Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Human Vaccine Companies in Global Market, by Revenue in 2020
3.7 Global Manufacturers Human Vaccine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Human Vaccine Players in Global Market
3.8.1 List of Global Tier 1 Human Vaccine Companies
3.8.2 List of Global Tier 2 and Tier 3 Human Vaccine Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Human Vaccine Market Size Markets, 2021 & 2027
4.1.2 Varicella
4.1.3 Influenza
4.1.4 Polio
4.1.5 Hepatitis A
4.1.6 Rabies
4.1.7 BCG
4.1.8 Hepatitis B
4.1.9 Pertussis, Diphtheria, Tetanus
4.1.10 Pneumococcal
4.1.11 Rota vaccine
4.2 By Type - Global Human Vaccine Revenue & Forecasts
4.2.1 By Type - Global Human Vaccine Revenue, 2016-2021
4.2.2 By Type - Global Human Vaccine Revenue, 2022-2027
4.2.3 By Type - Global Human Vaccine Revenue Market Share, 2016-2027
4.3 By Type - Global Human Vaccine Sales & Forecasts
4.3.1 By Type - Global Human Vaccine Sales, 2016-2021
4.3.2 By Type - Global Human Vaccine Sales, 2022-2027
4.3.3 By Type - Global Human Vaccine Sales Market Share, 2016-2027
4.4 By Type - Global Human Vaccine Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Human Vaccine Market Size, 2021 & 2027
5.1.2 Adults
5.1.3 Children
5.2 By Application - Global Human Vaccine Revenue & Forecasts
5.2.1 By Application - Global Human Vaccine Revenue, 2016-2021
5.2.2 By Application - Global Human Vaccine Revenue, 2022-2027
5.2.3 By Application - Global Human Vaccine Revenue Market Share, 2016-2027
5.3 By Application - Global Human Vaccine Sales & Forecasts
5.3.1 By Application - Global Human Vaccine Sales, 2016-2021
5.3.2 By Application - Global Human Vaccine Sales, 2022-2027
5.3.3 By Application - Global Human Vaccine Sales Market Share, 2016-2027
5.4 By Application - Global Human Vaccine Price (Manufacturers Selling Prices), 2016-2027
6 Sights by Region
6.1 By Region - Global Human Vaccine Market Size, 2021 & 2027
6.2 By Region - Global Human Vaccine Revenue & Forecasts
6.2.1 By Region - Global Human Vaccine Revenue, 2016-2021
6.2.2 By Region - Global Human Vaccine Revenue, 2022-2027
6.2.3 By Region - Global Human Vaccine Revenue Market Share, 2016-2027
6.3 By Region - Global Human Vaccine Sales & Forecasts
6.3.1 By Region - Global Human Vaccine Sales, 2016-2021
6.3.2 By Region - Global Human Vaccine Sales, 2022-2027
6.3.3 By Region - Global Human Vaccine Sales Market Share, 2016-2027
6.4 North America
6.4.1 By Country - North America Human Vaccine Revenue, 2016-2027
6.4.2 By Country - North America Human Vaccine Sales, 2016-2027
6.4.3 US Human Vaccine Market Size, 2016-2027
6.4.4 Canada Human Vaccine Market Size, 2016-2027
6.4.5 Mexico Human Vaccine Market Size, 2016-2027
6.5 Europe
6.5.1 By Country - Europe Human Vaccine Revenue, 2016-2027
6.5.2 By Country - Europe Human Vaccine Sales, 2016-2027
6.5.3 Germany Human Vaccine Market Size, 2016-2027
6.5.4 France Human Vaccine Market Size, 2016-2027
6.5.5 U.K. Human Vaccine Market Size, 2016-2027
6.5.6 Italy Human Vaccine Market Size, 2016-2027
6.5.7 Russia Human Vaccine Market Size, 2016-2027
6.5.8 Nordic Countries Human Vaccine Market Size, 2016-2027
6.5.9 Benelux Human Vaccine Market Size, 2016-2027
6.6 Asia
6.6.1 By Region - Asia Human Vaccine Revenue, 2016-2027
6.6.2 By Region - Asia Human Vaccine Sales, 2016-2027
6.6.3 China Human Vaccine Market Size, 2016-2027
6.6.4 Japan Human Vaccine Market Size, 2016-2027
6.6.5 South Korea Human Vaccine Market Size, 2016-2027
6.6.6 Southeast Asia Human Vaccine Market Size, 2016-2027
6.6.7 India Human Vaccine Market Size, 2016-2027
6.7 South America
6.7.1 By Country - South America Human Vaccine Revenue, 2016-2027
6.7.2 By Country - South America Human Vaccine Sales, 2016-2027
6.7.3 Brazil Human Vaccine Market Size, 2016-2027
6.7.4 Argentina Human Vaccine Market Size, 2016-2027
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Human Vaccine Revenue, 2016-2027
6.8.2 By Country - Middle East & Africa Human Vaccine Sales, 2016-2027
6.8.3 Turkey Human Vaccine Market Size, 2016-2027
6.8.4 Israel Human Vaccine Market Size, 2016-2027
6.8.5 Saudi Arabia Human Vaccine Market Size, 2016-2027
6.8.6 UAE Human Vaccine Market Size, 2016-2027
7 Manufacturers & Brands Profiles
7.1 CNBG
7.1.1 CNBG Corporate Summary
7.1.2 CNBG Business Overview
7.1.3 CNBG Human Vaccine Major Product Offerings
7.1.4 CNBG Human Vaccine Sales and Revenue in Global (2016-2021)
7.1.5 CNBG Key News
7.2 Changsheng Life
7.2.1 Changsheng Life Corporate Summary
7.2.2 Changsheng Life Business Overview
7.2.3 Changsheng Life Human Vaccine Major Product Offerings
7.2.4 Changsheng Life Human Vaccine Sales and Revenue in Global (2016-2021)
7.2.5 Changsheng Life Key News
7.3 Zhifei
7.3.1 Zhifei Corporate Summary
7.3.2 Zhifei Business Overview
7.3.3 Zhifei Human Vaccine Major Product Offerings
7.3.4 Zhifei Human Vaccine Sales and Revenue in Global (2016-2021)
7.3.5 Zhifei Key News
7.4 ChengDa Bio
7.4.1 ChengDa Bio Corporate Summary
7.4.2 ChengDa Bio Business Overview
7.4.3 ChengDa Bio Human Vaccine Major Product Offerings
7.4.4 ChengDa Bio Human Vaccine Sales and Revenue in Global (2016-2021)
7.4.5 ChengDa Bio Key News
7.5 Kangtai
7.5.1 Kangtai Corporate Summary
7.5.2 Kangtai Business Overview
7.5.3 Kangtai Human Vaccine Major Product Offerings
7.5.4 Kangtai Human Vaccine Sales and Revenue in Global (2016-2021)
7.5.5 Kangtai Key News
7.6 SINOVAC BIOTECH
7.6.1 SINOVAC BIOTECH Corporate Summary
7.6.2 SINOVAC BIOTECH Business Overview
7.6.3 SINOVAC BIOTECH Human Vaccine Major Product Offerings
7.6.4 SINOVAC BIOTECH Human Vaccine Sales and Revenue in Global (2016-2021)
7.6.5 SINOVAC BIOTECH Key News
7.7 Hissen
7.7.1 Hissen Corporate Summary
7.7.2 Hissen Business Overview
7.7.3 Hissen Human Vaccine Major Product Offerings
7.4.4 Hissen Human Vaccine Sales and Revenue in Global (2016-2021)
7.7.5 Hissen Key News
7.8 Walvax Biotechnology
7.8.1 Walvax Biotechnology Corporate Summary
7.8.2 Walvax Biotechnology Business Overview
7.8.3 Walvax Biotechnology Human Vaccine Major Product Offerings
7.8.4 Walvax Biotechnology Human Vaccine Sales and Revenue in Global (2016-2021)
7.8.5 Walvax Biotechnology Key News
7.9 GSK
7.9.1 GSK Corporate Summary
7.9.2 GSK Business Overview
7.9.3 GSK Human Vaccine Major Product Offerings
7.9.4 GSK Human Vaccine Sales and Revenue in Global (2016-2021)
7.9.5 GSK Key News
7.10 SANOFI
7.10.1 SANOFI Corporate Summary
7.10.2 SANOFI Business Overview
7.10.3 SANOFI Human Vaccine Major Product Offerings
7.10.4 SANOFI Human Vaccine Sales and Revenue in Global (2016-2021)
7.10.5 SANOFI Key News
7.11 Rong An
7.11.1 Rong An Corporate Summary
7.11.2 Rong An Human Vaccine Business Overview
7.11.3 Rong An Human Vaccine Major Product Offerings
7.11.4 Rong An Human Vaccine Sales and Revenue in Global (2016-2021)
7.11.5 Rong An Key News
7.12 NuoCheng Bio
7.12.1 NuoCheng Bio Corporate Summary
7.12.2 NuoCheng Bio Human Vaccine Business Overview
7.12.3 NuoCheng Bio Human Vaccine Major Product Offerings
7.12.4 NuoCheng Bio Human Vaccine Sales and Revenue in Global (2016-2021)
7.12.5 NuoCheng Bio Key News
7.13 Hualan Bio
7.13.1 Hualan Bio Corporate Summary
7.13.2 Hualan Bio Human Vaccine Business Overview
7.13.3 Hualan Bio Human Vaccine Major Product Offerings
7.13.4 Hualan Bio Human Vaccine Sales and Revenue in Global (2016-2021)
7.13.5 Hualan Bio Key News
7.14 Tiantan biological
7.14.1 Tiantan biological Corporate Summary
7.14.2 Tiantan biological Business Overview
7.14.3 Tiantan biological Human Vaccine Major Product Offerings
7.14.4 Tiantan biological Human Vaccine Sales and Revenue in Global (2016-2021)
7.14.5 Tiantan biological Key News
7.15 Changchun Baike
7.15.1 Changchun Baike Corporate Summary
7.15.2 Changchun Baike Business Overview
7.15.3 Changchun Baike Human Vaccine Major Product Offerings
7.15.4 Changchun Baike Human Vaccine Sales and Revenue in Global (2016-2021)
7.15.5 Changchun Baike Key News
7.16 Adimmune
7.16.1 Adimmune Corporate Summary
7.16.2 Adimmune Business Overview
7.16.3 Adimmune Human Vaccine Major Product Offerings
7.16.4 Adimmune Human Vaccine Sales and Revenue in Global (2016-2021)
7.16.5 Adimmune Key News
7.17 Zhongyianke Biotech
7.17.1 Zhongyianke Biotech Corporate Summary
7.17.2 Zhongyianke Biotech Business Overview
7.17.3 Zhongyianke Biotech Human Vaccine Major Product Offerings
7.17.4 Zhongyianke Biotech Human Vaccine Sales and Revenue in Global (2016-2021)
7.17.5 Zhongyianke Biotech Key News
8 Global Human Vaccine Production Capacity, Analysis
8.1 Global Human Vaccine Production Capacity, 2016-2027
8.2 Human Vaccine Production Capacity of Key Manufacturers in Global Market
8.3 Global Human Vaccine Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Human Vaccine Supply Chain Analysis
10.1 Human Vaccine Industry Value Chain
10.2 Human Vaccine Upstream Market
10.3 Human Vaccine Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Human Vaccine Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
NEED Help?
If you need any help or guidance, please feel free to call us.
USA : +1 (661) 636 6162
INDIA : +91 9325802062
or
Write us on : sales@kandjmarketresearch.com